Access cutting-edge copd treatment through this clinical trial at a research site in Birmingham. Study-provided care at no cost to qualified participants.
Access copd specialists in Birmingham at no cost
This study follows strict safety protocols and ethical guidelines
All study-related copd treatment provided free
The purpose of this study is to assess the long-term safety and to explore the efficacy of astegolimab in participants with chronic obstructive pulmonary disease (COPD) who have completed the 52-week placebo-controlled treatment period in parent studies GB43311 or GB44332.
Sponsor: Hoffmann-La Roche
Check if you qualify for this copd clinical trial in Birmingham, AL
If you're searching for copd treatment options in Birmingham, AL, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Birmingham research site is actively enrolling participants for this clinical trial. You'll receive care from experienced copd specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.